TRPA1 and myocardial infarction: Treatment with the TRPA1 inhibitor HC-030031 (HC) post-MI resulted in improved cardiac function, reduced myocardial apoptosis, and ameliorated pathological changes, including reduced infarct size and cardiac fibrosis.